AUROPHARMANSEAurobindo Pharma Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 19 Feb, 2026 · 15:13 IST

GST department orders Rs 170 crore recovery from Aurobindo Pharma

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹1168.60
prior close
₹1176.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-1.6%+1.9% vs market
Pharmaceuticals peers, median of 157sector-1.2%+1.5% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Midcap 150 and 1.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.3
15m
-0.4
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3-1.6+1.9-1.2+1.5
Next day
-1.0-1.1+0.1-1.4+0.4
2d
-1.7-1.3-0.4-1.6-0.1
3d
-0.5-1.5+1.1-2.1+1.6
4d
+4.0-0.9+4.9-2.4+6.4
5d
+4.5-0.3+4.9-2.0+6.5
1w
+3.7-3.1+6.8-4.6+8.3
15d
+11.2-8.7+19.9-6.8+18.0
1m
+7.2-9.3+16.5-7.5+14.7
2m
+16.8-0.6+17.5+0.5+16.3
3m
+29.5+1.0+28.6+3.2+26.4
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The GST department has passed 4 orders demanding recovery of refunds worth about Rs 169.84 crore (Rs 84.92 crore tax plus Rs 84.92 crore penalty) from Aurobindo's EOU Unit 3. The refunds relate to accumulated Input Tax Credit during September to December 2022 on zero-rated exports. The department claims similar products exist in the domestic market. The company says there is no material financial or operational impact and will appeal before the Commissioner of Central Tax (Appeals), Hyderabad. Writ petitions challenging Rule 89(4)(C) of CGST Rules are pending in the Telangana High Court.

Likely market impact

Tax demand of about Rs 170 crore but company says no material financial impact and plans to appeal. Watch writ petition outcome.